Adenoviral vectors—How to use them in cancer gene therapy?
- 1 August 2006
- journal article
- review article
- Published by Elsevier in Virus Research
- Vol. 119 (2) , 121-133
- https://doi.org/10.1016/j.virusres.2006.02.001
Abstract
No abstract availableKeywords
This publication has 129 references indexed in Scilit:
- Combination effect of oncolytic adenovirotherapy and TRAIL gene therapy in syngeneic murine breast cancer modelsCancer Gene Therapy, 2005
- Adenovirus-mediated p53 gene therapy in pediatric soft-tissue sarcoma cell lines: sensitization to cisplatin and doxorubicinCancer Gene Therapy, 2004
- Adenoviral Serotype 5 Vectors Pseudotyped with Fibers from Subgroup D Show Modified TropismIn VitroandIn VivoHuman Gene Therapy, 2004
- A phase I study of Adp53 (INGN 201; ADVEXIN) for patients with platinum- and paclitaxel-resistant epithelial ovarian cancerGynecologic Oncology, 2004
- A Genetically Retargeted Adenoviral Vector Enhances Viral Transduction in Esophageal Carcinoma Cell Lines and Primary Cultured Esophageal Resection SpecimensAnnals of Surgery, 2003
- Expression of the coxsackie and adenovirus receptor in human astrocytic tumors and xenograftsInternational Journal of Cancer, 2002
- Modulation of Adenovirus Vector Tropism via Incorporation of Polypeptide Ligands into the Fiber ProteinJournal of Virology, 2002
- Phage Display of Adenovirus Type 5 Fiber Knob as a Tool for Specific Ligand Selection and ValidationJournal of Virology, 2001
- Does the Antitumor Adenovirus ONYX-015/dl1520 Selectively Target Cells Defective in the p53 Pathway?Journal of Virology, 2001
- New triple-helical model for the shaft of the adenovirus fibreJournal of Molecular Biology, 1992